ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, ...
To understand how these forces are landing with physicians, we fielded a real-time SERMO survey (January 5-6, 2026) among U.S. physicians across oncology, neurology and allergy/immunology. What we ...
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise awareness and deepen ...
– Co-Founder, President and CTO Paul Bertin, Ph.D., and Scientific Founder Nathan Gianneschi, Ph.D., to Present Progress with Company’s Bionic Biologics™ Platform – CHICAGO–(BUSINESS WIRE)–August 15, ...
Budget 2026: the Biopharma SHAKTI with an outlay of Rs. 10,000 crores over five years, aimed at strengthening India’s ...
ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results